Albireo Pharma (ALBO)
NASDAQ:ALBO

Albireo Pharma (ALBO) Stock Forecast & Price Target

587 Followers
See the Price Targets and Ratings of:

ALBO Analyst Ratings

Strong Buy
5Ratings
5 Buy
0 Hold
0 Sell
Based on 5 analysts giving stock ratings to
Albireo
Pharma
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ALBO Stock 12 Months Forecast

Average Price Target

$56.20
▲(154.88% Upside)
Based on 5 Wall Street analysts offering 12 month price targets for Albireo Pharma in the last 3 months. The average price target is $56.20 with a high forecast of $68.00 and a low forecast of $50.00. The average price target represents a 154.88% change from the last price of $22.05.
Highest Price Target$68.00Average Price Target$56.20Lowest Price Target$50.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
William Blair
Buy
Reiterated
Maintain "Confidence Bylvay Could Become the Best-in-Class Agent" - William Blair reiterates Outperform Rating on Albireo Pharma (ALBO)William Blair analyst Tim Lugo reiterated an Outperform rating on Albireo Pharma (NASDAQ: ALBO), following the companys recent presentation at Annual Growth Stock Conference.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

ALBO Financial Forecast

ALBO Earnings Forecast
Next quarter’s earnings estimate for ALBO is -$1.99 with a range of -$2.15 to -$1.86. The previous quarter’s EPS was -$1.92. ALBO beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.43% of the time in the same period. In the last calendar year ALBO has Underperformed its overall industry.
Next quarter’s earnings estimate for ALBO is -$1.99 with a range of -$2.15 to -$1.86. The previous quarter’s EPS was -$1.92. ALBO beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.43% of the time in the same period. In the last calendar year ALBO has Underperformed its overall industry.
ALBO Sales Forecast
Next quarter’s sales forecast for ALBO is $9.88M with a range of $8.60M to $10.83M. The previous quarter’s sales results were $9.83M. ALBO beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 42.85% of the time in the same period. In the last calendar year ALBO has Outperformed its overall industry.
Next quarter’s sales forecast for ALBO is $9.88M with a range of $8.60M to $10.83M. The previous quarter’s sales results were $9.83M. ALBO beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 42.85% of the time in the same period. In the last calendar year ALBO has Outperformed its overall industry.
ALBO Analyst Recommendation Trends
In the current month, ALBO has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ALBO average analyst price target in the past 3 months is $56.20
In the current month, ALBO has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ALBO average analyst price target in the past 3 months is $56.20

ALBO Stock Forecast FAQ

What is ALBO’s average 12-month price target, according to analysts?
Based on analyst ratings, Albireo Pharma’s 12-month average price target is $56.20.
    What is ALBO’s upside potential, based on the analysts’ average price target?
    Albireo Pharma has 154.88% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ALBO a Buy, Sell or Hold?
          Albireo Pharma has a conensus rating of Strong Buy which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Albireo Pharma’s price target?
            The average price target for Albireo Pharma is $56.20. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $68.00 ,the lowest forecast is $50.00. The average price target represents 154.88% Increase from the current price of $22.05.
              What do analysts say about Albireo Pharma?
              Albireo Pharma’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis